5500nok
-0,9 %
Date:2024-03-27Time:17:30:00Latest report:Q4-2023List:Oslo BorsTicker:PHO
Market Cap:1 492 mnokEnterprise Value:1 232 mnokNet Sales:446,2 mnokEarnings:0,27 mnokEmployees:0ISIN:NO0010000045

Ratios

10-year key figure history for Photocure turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Photocure with index and moving average MA50 and MA200.

Stockprice:55,00
MA50:59,86
MA200:54,48
Price/MA200:1,0 %
RSI (14):43,0
Price/MA50:-8,1 %

Description

PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, Netherlands, Other European countries, and the United States.

Pharmaceuticals